Brief From our Editor -- ICON (ICLR) Stock.

Large-cap Health Care company ICON has logged a -2.9% change today on a trading volume of 616,565. The average volume for the stock is 745,744.

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. Based in Dublin, Ireland the company has 41,150 full time employees and a market cap of $19,911,059,456.

The company is now trading -3.06% away from its average analyst target price of $250.69 per share. The 13 analysts following the stock have set target prices ranging from $220.0 to $281.0, and on average give ICON a rating of buy.

Over the last year, ICLR shares have gone up 1558.2%, which represents a difference of -57.0% when compared to the S&P 500. The stock's 52 week high is $252.15 per share whereas its 52 week low is $171.43. With its gross margins declining a compounded average of -0.9% over the last 4 years, ICON may not have a strong enough business to maintain this trend.

Date Reported Revenue ($ k) Cost of Revenue ($ k) Gross Margins (%) YoY Growth (%)
2022-12-31 7,741,386 5,527,045 28.6 3.92
2021-12-31 5,480,826 3,972,612 27.52 -4.74
2020-12-31 2,797,288 1,989,256 28.89 -2.53
2019-12-31 2,805,839 1,974,135 29.64 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS